Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Correction to: Genetics in Medicine 23: 927–933; 10.1038/s41436-020-01073-x; Article published online 26 January 2021

The risk alleles of rs1964986 (PRSS1) and rs959173 (CAV1) should be the C allele for both variants instead of the A and T alleles listed in the paper. The changes have been reflected in both Figure 1 and Table 2 shown below.

The original article has been corrected.

Table 2.

Effect sizes (hazard ratios) and the 95% confidence intervals (CIs) fitted using a multivariate Cox PH model in the CGS. Risk allele/risk group noted in parentheses after the listed predictor.

Gene annotation	Predictor	Hazard ratio	95% CI
CFTR	CFTR mutation score	3.02	(2.01, 4.54)
—	Sex (female)	1.48	(1.26, 1.74)
SLC5A8	rs12318809 (G)	1.35	(1.16, 1.57)
CAV1	rs959173 (C)	1.27	(1.10, 1.47)
PRSS1	rs1964986 (C)	1.23	(1.09, 1.38)
SLC26A9	rs4077468 (A)	1.20	(1.07, 1.34)
NRG1	rs7822917 (T)	1.31	(1.16, 1.48)
—	Meconium ileus (MI)	1.29	(1.05, 1.59)
TCF7L2	rs7903146 (T)	1.18	(1.05, 1.34)